P2RY12 and coronary artery disorder: Dual-antiplatelet therapy using P2Y12 inhibitors and aspirin is the gold standard treatment in patients with coronary artery disease undergoing percutaneous coronary intervention (PCI) to prevent coronary events, such as stent thrombosis [1].